Compare KVUE & SYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KVUE | SYY |
|---|---|---|
| Founded | 2022 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Food Distributors |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.2B | 39.9B |
| IPO Year | 2023 | 2004 |
| Metric | KVUE | SYY |
|---|---|---|
| Price | $19.79 | $83.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 14 |
| Target Price | $19.50 | ★ $91.08 |
| AVG Volume (30 Days) | ★ 16.5M | 3.3M |
| Earning Date | 10-30-2026 | 11-03-2026 |
| Dividend Yield | ★ 4.41% | 2.68% |
| EPS Growth | ★ 40.74 | N/A |
| EPS | 0.48 | ★ 3.66 |
| Revenue | $15,124,000,000.00 | ★ $84,553,000,000.00 |
| Revenue This Year | $3.12 | $6.48 |
| Revenue Next Year | $2.38 | $2.27 |
| P/E Ratio | $39.79 | ★ $22.45 |
| Revenue Growth | N/A | ★ 3.91 |
| 52 Week Low | $14.02 | $68.19 |
| 52 Week High | $20.13 | $91.85 |
| Indicator | KVUE | SYY |
|---|---|---|
| Relative Strength Index (RSI) | 73.12 | 65.33 |
| Support Level | $18.67 | $82.33 |
| Resistance Level | $20.09 | $85.05 |
| Average True Range (ATR) | 0.31 | 1.32 |
| MACD | 0.25 | 0.68 |
| Stochastic Oscillator | 98.52 | 98.72 |
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
Sysco is the largest foodservice distributor in the US, with an 18% share of the $377 billion vertical. The firm sells and distributes over 500,000 food and nonfood products to about 730,000 customer locations, primarily serving restaurants, which represented 60% of fiscal 2025 sales. The balance of sales stems from healthcare facilities (8%), education and government customers (8%), travel and leisure clients (7%), and other smaller end markets (17%), like cafeterias. By segment, Sysco earns the bulk of its revenue from its US foodservice operations (70%), followed by its international footprint (18%), SYGMA, which focuses on quick-service logistics (10%), and other (2%). The pending Jetro Restaurant Depot deal stands to add $16 billion in sales upon close, expected in fiscal 2027.